Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
85.60
+2.12 (2.54%)
May 12, 2025, 3:28 PM - Market open
Medtronic Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Medtronic stock have an average target of 94.71, with a low estimate of 76 and a high estimate of 109. The average target predicts an increase of 10.64% from the current stock price of 85.60.
Analyst Consensus: Hold
* Price targets were last updated on Apr 11, 2025.
Analyst Ratings
The average analyst rating for Medtronic stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 5 | 5 | 5 | 5 | 5 | 5 |
Hold | 8 | 8 | 8 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Total | 16 | 16 | 16 | 15 | 15 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $93 → $90 | Hold | Maintains | $93 → $90 | +5.14% | Apr 11, 2025 |
Citigroup | Citigroup | Hold → Strong Buy Upgrades $92 → $107 | Hold → Strong Buy | Upgrades | $92 → $107 | +25.00% | Mar 4, 2025 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 19, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $105 | Buy | Reiterates | $105 | +22.66% | Feb 19, 2025 |
UBS | UBS | Hold Maintains $85 → $95 | Hold | Maintains | $85 → $95 | +10.98% | Feb 19, 2025 |
Financial Forecast
Revenue This Year
33.83B
from 32.36B
Increased by 4.52%
Revenue Next Year
35.34B
from 33.83B
Increased by 4.47%
EPS This Year
5.51
from 2.76
Increased by 99.57%
EPS Next Year
5.89
from 5.51
Increased by 6.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 35.3B | 37.5B | 39.4B | |||
Avg | 33.8B | 35.3B | 37.1B | |||
Low | 32.7B | 33.9B | 35.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 9.1% | 10.7% | 11.5% | |||
Avg | 4.5% | 4.5% | 5.1% | |||
Low | 1.0% | 0.2% | 0.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 5.74 | 6.32 | 6.82 | |||
Avg | 5.51 | 5.89 | 6.35 | |||
Low | 5.32 | 5.61 | 5.97 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 108.1% | 14.8% | 15.9% | |||
Avg | 99.6% | 6.9% | 7.8% | |||
Low | 92.8% | 1.8% | 1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.